Group integrated exercise versus recovery class for veterans with posttraumatic stress disorder: a randomized clinical trial

被引:0
作者
Neylan, Thomas C. [1 ,2 ,3 ,4 ,8 ]
Muratore, Laura A. [1 ,2 ,3 ]
Williams, Chanda L. [1 ,3 ,5 ]
Schmitz, Martha [1 ,2 ]
Valdez, Courtney V. [1 ,2 ]
Maguen, Shira [1 ,2 ,3 ]
O'Donovan, Aoife [1 ,2 ,3 ]
Kelley, D. Parker [1 ,2 ,3 ]
Metzler, Thomas J. [1 ,2 ,3 ]
Cohen, Beth E. [1 ,3 ,6 ]
West, Anna C. [1 ,2 ,3 ]
Phan, Jordan D. V. [1 ,2 ,3 ]
Antonetti, Victor [1 ,3 ]
Mayzel, Olga [1 ,2 ,3 ]
Hlavin, Jennifer A. [1 ,2 ,3 ]
Chesney, Margaret A. [1 ,2 ,6 ]
Mehling, Wolf E. [1 ,5 ,7 ]
机构
[1] San Francisco VA Med Ctr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Psychiat & Behav Sci, San Francisco, CA 94115 USA
[3] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA
[4] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA
[5] Univ Calif San Francisco, Osher Ctr Integrat Hlth, San Francisco, CA USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA USA
[8] Univ Calif San Francisco, San Francisco VA Hlth Care Syst, 116-P 4150 Clement St, San Francisco, CA 94121 USA
关键词
PTSD; Veteran; Randomized controlled trial; Exercise; Psychoeducation; SLEEP QUALITY INDEX; EMOTION REGULATION; ILLNESS MANAGEMENT; MINDFULNESS; PROGRAM; VALIDATION; REDUCTION; SYMPTOMS; BEHAVIOR; ADULTS;
D O I
10.1186/s12888-025-06638-1
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There are no reported randomized trials testing exercise versus an active comparator for Posttraumatic Stress Disorder (PTSD). This randomized clinical trial assessed the effectiveness of group exercise versus psychoeducation to improve quality of life and reduces symptomatic severity in Veterans with PTSD. Veterans who met criteria for current PTSD (DSM-5) and/or endorsed moderate levels of PTSD symptoms (CAPS 5 score >= 23) were randomly assigned to treatment. Integrative Exercise (IE) combines fitness exercises (aerobics, resistance training, stretching) with mindful body/breath awareness versus Recovery Class (REC) psychoeducation control condition. A total of 84 participants were enrolled of which 41 participants were randomized to IE and 43 participants to REC. There were no significant pre-post differences in change in the WHOQOL Psychological Domain in either group. There was a modest reduction in the total CAPS-5 score in both groups (IE: -8.2 (9.9), p < .001: REC: -7.8 (2.0), p < .001) but no differences across the two conditions. In the IE subsample that was remote, there was a greater improvement in PTSD symptom severity (F[1, 50] = 4.62, p = .036) and in in the WHOQOL Psychological Domain (F(1, 47) = 6.46, p = .014) in those who attended more sessions.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Efficacy of Vortioxetine Monotherapy for Posttraumatic Stress Disorder A Randomized, Placebo-Controlled Trial
    Dunlop, Boadie W.
    Rakofsky, Jeffrey J.
    Newport, D. Jeffrey
    Mletzko-Crowe, Tanja
    Barone, Katelyn
    Nemeroff, Charles B.
    Harvey, Philip D.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (02) : 172 - 179
  • [42] Randomized trial of trauma-focused group therapy for posttraumatic stress disorder - Results from a Department of Veterans Affairs Cooperative Study
    Schnurr, PP
    Friedman, MJ
    Foy, DW
    Shea, MT
    Hsieh, FY
    Lavori, PW
    Glynn, SM
    Wattenberg, M
    Bernardy, NC
    ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (05) : 481 - 489
  • [43] A randomized controlled trial of ganaxolone in posttraumatic stress disorder
    Ann M. Rasmusson
    Christine E. Marx
    Sonia Jain
    Gail M. Farfel
    Julia Tsai
    Xiaoying Sun
    Thomas D. Geracioti
    Mark B. Hamner
    James Lohr
    Richard Rosse
    Lanier Summerall
    Jennifer C. Naylor
    Cristine Cusin
    Ariel J. Lang
    Rema Raman
    Murray B. Stein
    Psychopharmacology, 2017, 234 : 2245 - 2257
  • [44] Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: A randomized open label trial
    Chung, MY
    Min, KH
    Jun, YJ
    Kim, SS
    Kim, WC
    Jun, EM
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (07) : 489 - 494
  • [45] Attentional Bias Modification in Posttraumatic Stress Disorder: A Randomized Controlled Trial
    Schoorl, Maartje
    Putman, Peter
    Van der Does, Willem
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2013, 82 (02) : 99 - 105
  • [46] Comparing Effectiveness of Residential Versus Intensive Virtual Treatment for Veterans With Posttraumatic Stress Disorder
    Craig, Katherine M.
    Bryan, Brandon C.
    O'Connor, Victoria L.
    Richard, Kevin W.
    Landwehr, Amanda E.
    Martindale, Sarah L.
    PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2024, 16 : S627 - S635
  • [47] Adapting the Multifamily Group Model for Treating Veterans With Posttraumatic Stress Disorder
    Sherman, Michelle D.
    Perlick, Deborah A.
    Straits-Troester, Kristy
    PSYCHOLOGICAL SERVICES, 2012, 9 (04) : 349 - 360
  • [48] Evaluation of a hybrid treatment for Veterans with comorbid traumatic brain injury and posttraumatic stress disorder: Study protocol for a randomized controlled trial
    Jak, Amy J.
    Aupperle, Robin
    Rodgers, Carie S.
    Lang, Ariel J.
    Schiehser, Dawn M.
    Norman, Sonya B.
    Twamley, Elizabeth W.
    CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 210 - 216
  • [49] A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder
    Sippel, Lauren M.
    King, Courtney E.
    Wahlquist, Amy E.
    Flanagan, Julianne C.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (04) : 401 - 404
  • [50] Contingency management and cognitive behavior therapy for smoking cessation among veterans with posttraumatic stress disorder: Design and methodology of a randomized clinical trial
    Wells, Stephanie Y.
    LoSavio, Stefanie T.
    Patel, Tapan A.
    Evans, Mariah K.
    Beckham, Jean C.
    Calhoun, Patrick
    Dedert, Eric A.
    CONTEMPORARY CLINICAL TRIALS, 2022, 119